Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can intensive statin therapy cause regression of coronary atherosclerosis?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages 354–355 (2006)Cite this article

boxed-textNissen SE et al. (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. The ASTEROID Trial. JAMA 295: 1556–1565

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Watts GF et al. (1992) Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339: 563–569

    Article  CAS  Google Scholar 

  2. Ornish D et al. (1998) Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280: 2001–2007

    Article  CAS  Google Scholar 

  3. LaRosa JC et al.; Treating to New Targets (TNT) Investigators (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352: 1425–1435

    Article  CAS  Google Scholar 

  4. Mann J and Davies MJ (1999) Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 82: 265–268

    Article  CAS  Google Scholar 

  5. Raggi P et al. (2005) Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 112: 563–571

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. University of Edinburgh and Consultant Cardiologist in the Department of Cardiology, Professor of Cardiology at the Centre for Cardiovascular Sciences, Royal Infirmary, Edinburgh and St John's Hospital, Livingston, UK

    David E Newby

Authors
  1. David E Newby
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

DE Newby holds, or has held, unrestricted educational grant awards for Bristol-Myers Squibb, Pfizer and R.W. Johnson. He has undertaken paid consultancy for AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer and Johnson & Johnson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Newby, D. Can intensive statin therapy cause regression of coronary atherosclerosis?. Nat Rev Cardiol 3, 354–355 (2006). https://doi.org/10.1038/ncpcardio0604

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0604

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing